Breaking News on Drug DiscoveryDaily
Thursday 26 July 2007
Forward to a colleague |
|
|
| Breaking News on Drug Discovery |
||
|
||
| Daily
Thursday 26 July 2007 |
Forward to a colleague |
|
|
Sponsored Message  New Nanoliter Pipetting with an approved Simultaneous Pipettor CyBio has introduced an innovative enhancement in simultaneous pipetting, two new exchangeable modules for Nanoliter parallel pipetting further extending the broad range of applications of the proven CyBio®-Well vario pipetting platform... Click Here Access Full Stories  Panacos develops new class of fusion inhibitorsPanacos, a US based pharma firm, has outlined its work to identify three new series of compounds that inhibit HIV fusion at a different site to the only approved fusion inhibitor, Roche's Fuzeon (enfuvirtide)... Read SwitchGear screens signalling-pathways SwitchGear Genomics has launched a new high-throughput (HT) tool that allows researchers to peer into disease-related pathways and study how potential drugs affect disease progression... Read Early stage biz boosts Covance Q2 Covance has posted strong financial results for the second quarter of the year, mainly driven by its early-stage development business performance... Read Cell Therapeutics expands in cancer with SMi buy Cell Therapeutics has acquired oncology expert Systems Medicine (SMi) in a deal worth up to $35m (€25.5m) that includes worldwide rights to brostallicin that belongs to a new class of cancer drugs... Read Benitec's three-pronged RNA attack on HIV Australian biotech company, Benitec, is about to start dosing patients in the first ever human trial of its RNA therapy, which attacks HIV on three separate fronts... Read |
|
||||||||
All News Headlines for: July | June | May |
||||||||||
 Product OverviewA revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here |
||||||||||
|
Related Industry News Novel soft mist COPD inhaler set for EU A novel spring-powered inhaler system to deliver the blockbuster COPD (chronic obstructive pulmonary disease) treatment Spiriva (tiotropium) has successfully completed the EU approval process, paving the way for... Read Don't trust 'Old Faithful' when pipetting hot liquids Artel's extreme pipetting expedition team went to Yellowstone National Park, US, where they found that pipetting hot or cold liquids can cause delivery volume errors of up to 37 per cent... Read First dissolution-focused CRO launched Lab equipment specialist Sotax has announced the creation of a new contract research organisation (CRO) focused exclusively on dissolution testing services... Read Vivalis cell lines show MAb production power French firm Vivalis has announced the first data evaluating its proprietary EBx cell lines for the production of monoclonal antibodies (MAbs), with initial results suggesting high cytotoxic properties in the resultant... Read
|
||||||||||
|
|||
| Forward to a colleague |
|||
|
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
|
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||
Free Newsletters for
Pharmaceuticals